MX2019011389A - Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico. - Google Patents
Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico.Info
- Publication number
- MX2019011389A MX2019011389A MX2019011389A MX2019011389A MX2019011389A MX 2019011389 A MX2019011389 A MX 2019011389A MX 2019011389 A MX2019011389 A MX 2019011389A MX 2019011389 A MX2019011389 A MX 2019011389A MX 2019011389 A MX2019011389 A MX 2019011389A
- Authority
- MX
- Mexico
- Prior art keywords
- supression
- sustained
- rapid
- immediate release
- subject
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se dirige a equipos, combinaciones y usos de las composiciones para tratar, evitar o reducir el riesgo de desarrollar un desorden o enfermedades gastrointestinal, o los síntomas asociados con, o relacionados a un desorden o enfermedad gastrointestinal en un sujeto que lo requiere. En un aspecto, la presente invención proporciona una composición farmacéutica que comprende un agente inhibidor de bomba de protones y un agente amortiguador para administración oral a un sujeto. Ante administración, la composición contacta el fluido gástrico del estómago y aumenta el pH de fluido gástrico del estómago a un pH que substancialmente evita o inhibe la degradación ácida del agente inhibidor de bomba de protones en el fluido gástrico y permite que una concentración en suero medible del agente inhibidor de bomba de protones sea absorbida en el suero de la sangre del sujeto.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44862703P | 2003-02-20 | 2003-02-20 | |
| US10/938,766 US20050220870A1 (en) | 2003-02-20 | 2004-09-10 | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019011389A true MX2019011389A (es) | 2019-11-07 |
Family
ID=36775535
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05008804A MXPA05008804A (es) | 2003-02-20 | 2004-02-20 | Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico. |
| MX2019011389A MX2019011389A (es) | 2003-02-20 | 2005-08-18 | Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05008804A MXPA05008804A (es) | 2003-02-20 | 2004-02-20 | Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico. |
Country Status (1)
| Country | Link |
|---|---|
| MX (2) | MXPA05008804A (es) |
-
2004
- 2004-02-20 MX MXPA05008804A patent/MXPA05008804A/es unknown
-
2005
- 2005-08-18 MX MX2019011389A patent/MX2019011389A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05008804A (es) | 2006-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200509923A (en) | A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid | |
| ES2845635T3 (es) | Composición y método para la unión de acetaldehído en el estómago | |
| BRPI0608039A2 (pt) | células cancerìgenas sensìveis aos inibidores da histona deacetilase | |
| AR038157A1 (es) | Formas de dosificacion de benzimidazoles sustituidos y su uso | |
| MX2010001071A (es) | Formas de dosificacion retentivas gastricas pulsatiles. | |
| JP2010529197A (ja) | 酸化的ストレス関連疾患の治療および診断のための材料および方法 | |
| CO6260019A2 (es) | Metodos para el tratamiento de desordenes gastrointestinales independientes de la ingesta de alimento | |
| NO20084542L (no) | Farmasoytisk kombinasjon inneholdende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol | |
| WO2015194034A1 (ja) | 尿酸値低下剤 | |
| Tiev et al. | Digestive tract involvement in systemic sclerosis | |
| Salim | Sulphydryl-containing agents: a new approach to the problem of refractory peptic ulceration | |
| Lim et al. | In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine | |
| MX2019011389A (es) | Una formulacion novedosa, complejo antiacido de omeprazol de liberacion inmediata para supresion rapida y sostenida de acido gastrico. | |
| Li Voti et al. | Relationship between upper gastrointestinal bleeding and non steroidal anti-inflammatory drugs in children | |
| US20160022620A1 (en) | Encapsulated composition for binding aldehydes in the stomach | |
| Kechagias et al. | Influence of age, sex, and Helicobacter pylori infection before and after eradication on gastric alcohol dehydrogenase activity | |
| Gisbert | Enfermedades relacionadas con la infección por Helicobacter pylori | |
| Katopodis et al. | Effectiveness of aluminum hydroxide timing administration in relation to meals in controling hyperphosphatemia in dialysis patients | |
| Pokhrel et al. | Effectiveness of iron-based phosphate binders in reduction of hyperphosphataemia in chronic kidney disease patients | |
| Yamabe et al. | A new pharyngitis model using capsaicin in rats | |
| Kumar et al. | Biochemical Estimation of High Dose of Omeprazole in Experimental Rodents. | |
| Shimizu et al. | ACE inhibitor and swallowing difficulties in stroke | |
| EP2996687A1 (en) | Cysteine or a derivative thereof for the treatment of atrophic gastritis | |
| General | Gastrointestinal disease 358 | |
| Higuchi et al. | Dipeptidyl peptidase IV inhibition potentiates amino acid |